Innovative Endpoints in Alzheimer’s Disease Clinical Trials
Speaker
Dr. Jort Vijverberg
Neurologist
Dr. Jort Vijverberg is a neurologist at the Brain Research Center and a senior researcher at Alzheimercentrum Amsterdam. He has been the principal investigator on many Alzheimer’s clinical trials and consults with the pharmaceutical industry.
Together with our partner Brain Research Center, we presented the webinar:
Innovative Endpoints in Alzheimer’s Disease Clinical trials.
During this webinar, two experts in the field, Dr. Niels Prins and Dr. Jort Vijverberg discussed the latest clinical and biomarker endpoints.
During this webinar our experts expanded on how we advance clinical drug development for Alzheimer’s disease by touching upon:
> Biomarker-based participant selection;
> inclusion criteria for upcoming AD trials
> Fluid biomarkers as endpoints in your AD trial;
> EEG; a ‘novel’ AD biomarker.
Related webinars
Webinar – Time to event trial designs in ALS: How useful are they?
On NOVEMBER 26th, 2024, we organised the webinar: Time to event trial designs in ALS: How useful are they? During this webinar, our speakers Ruben van Eijk, Lotte Smets, Jordi van Unnik and host Lieza Exalto explored the following topics:A...
Webinar – Clinical consequences of the New MASLD Nomenclature
On the 27th of June, we organized the webinar: 'Clinical Consequences of the New MASLD Nomenclature' with guest speaker Prof. Maja Thiele.During this webinar, our speaker and hosts dived into the following topics:Is the MASLD nomeclature...
Webinar: Plasma biomarkers for diagnosis and monitoring of neurodegenerative disorders
On October 15, at 16.00 CEST, we presented the webinar:Plasma biomarkers for diagnosis and monitoring of neurodegenerative disordersTopics that are discussed:Plasma biomarkers, such as Amyloid, pTau and NfL. Treatment effect in ne...